Boxer Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,602,200
| Closed | -$24.5M | – | 43 |
|
|
2024
Q3 | $24.5M | Hold |
1,602,200
| – | – | 1.2% | 22 |
|
|
2024
Q2 | $24.4M | Hold |
1,602,200
| – | – | 1.29% | 24 |
|
|
2024
Q1 | $30.2M | Hold |
1,602,200
| – | – | 1.49% | 20 |
|
|
2023
Q4 | $30.6M | Hold |
1,602,200
| – | – | 1.53% | 21 |
|
|
2023
Q3 | $28.8M | Hold |
1,602,200
| – | – | 1.53% | 24 |
|
|
2023
Q2 | $32.5M | Buy |
1,602,200
+170,000
| +12% | +$3.45M | 1.51% | 20 |
|
|
2023
Q1 | $26.1M | Hold |
1,432,200
| – | – | 1.28% | 25 |
|
|
2022
Q4 | $29.6M | Hold |
1,432,200
| – | – | 1.56% | 21 |
|
|
2022
Q3 | $37.5M | Hold |
1,432,200
| – | – | 2.11% | 16 |
|
|
2022
Q2 | $36.3M | Hold |
1,432,200
| – | – | 2.3% | 17 |
|
|
2022
Q1 | $45.2M | Hold |
1,432,200
| – | – | 2.32% | 15 |
|
|
2021
Q4 | $58M | Sell |
1,432,200
-652,683
| -31% | -$26.4M | 2.25% | 13 |
|
|
2021
Q3 | $72.7M | Hold |
2,084,883
| – | – | 2.54% | 9 |
|
|
2021
Q2 | $57.3M | Hold |
2,084,883
| – | – | 2.02% | 10 |
|
|
2021
Q1 | $58.5M | Hold |
2,084,883
| – | – | 1.99% | 10 |
|
|
2020
Q4 | $54.1M | Hold |
2,084,883
| – | – | 1.74% | 14 |
|
|
2020
Q3 | $35.7M | Hold |
2,084,883
| – | – | 1.23% | 19 |
|
|
2020
Q2 | $51.6M | Sell |
2,084,883
-1,000,000
| -32% | -$24.7M | 2.27% | 10 |
|
|
2020
Q1 | $42.8M | Buy |
3,084,883
+1,412,650
| +84% | +$19.6M | 2.92% | 11 |
|
|
2019
Q4 | $16.9M | Buy |
1,672,233
+1,372,233
| +457% | +$13.9M | 0.96% | 30 |
|
|
2019
Q3 | $2.73M | Buy |
+300,000
| New | +$2.73M | 0.2% | 42 |
|